Default company panoramic image
4dc95bbc 1b6a 4b73 8988 84b7fa6003e8

Intezyne, Inc

Intezyne makes clinically proven drugs safer and more effective. By using our patented IVECT™ Method, Intezyne can increase both the circulation time of a d...

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Tampa, FL, USA
  • Currency USD
  • Founded June 2004
  • Employees 10
  • Website intezyne.com

Company Summary

Intezyne makes clinically proven drugs safer and more effective. By using our patented IVECT™ Method, Intezyne can increase both the circulation time of a drug and its accumulation in the target area (i.e. tumor), while reducing exposure of the drug to healthy areas of the body. Drugs encapsulated in Intezyne’s IVECT Method are safer and more effective treatments as compared to best-in-class drugs.

Team

  • Default avatar
    Habib Skaff
    CEO

    Habib Skaff, Ph.D. co-founded Intezyne and serves as the company’s Chief Executive Officer, President, and Chairman of the Board of Directors. Dr. Skaff also held the position of President and is currently the Chairman of Skaff Corporation of America (Tampa, Florida). Dr. Skaff, a synthetic chemist specializing in the area of nanotechnology, received a Ph.D. in Polymer Science and Engineering from the University of Massachusetts in 2005.